RxDoctor Payments Data

Richard Mark

Internal Medicine · New York, NYNPI 1003918905

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.0% of the total across 78 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 23 manufacturers, the largest accounting for just 16.8% — the pattern of someone who eats at a lot of different presentations.

$1,461in general payments, 2019–2025

Across 78 payments — averaging $18.73 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Johnson & Johnson$246
  • AbbVie$148
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$117
  • Kowa Pharmaceuticals America, Inc.$107
  • Novo Nordisk$83
  • Pfizer$74
  • plus $686 from 17 others

What the payments were for

  • Food & beverage$1,43298%
  • Education$302%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
22

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,461 in reported general payments places this provider in the 75th percentile of 9,771 internal medicine providers in New York.

See all internal medicine providers in New York →

Other internal medicine in New York

See the full list for New York →

Where these figures come from

Is this you, or does something look wrong? →